The Renal "Mechanome": Piezo1 as a Transducer of Shear, Tension, and Stiffness in Health and Kidney Disease.

Abstract

The kidney cells operate within a dynamic mechanical environment shaped by tubular fluid shear stress, glomerular capillary tension, and extracellular matrix stiffness. These physical forces are essential regulators of nephron development, epithelial specialization and structural integrity; yet the molecular systems that convert mechanical inputs into biological responses have remained incompletely defined. The discovery of Piezo1 as a mechanosensitive ion channel has reshaped this landscape, identifying a direct pathway through which membrane deformation is translated into intracellular cation flux and downstream signaling, mechanisms increasingly implicated in a spectrum of pediatric and adult disorders. Recent transcriptomic, imaging, and functional studies demonstrate that Piezo1 is broadly distributed along the nephron, where it contributes to flow sensing in tubular epithelia, cytoskeletal adaptation to glomerular pressure in podocytes, and stiffness detection within the interstitium. Emerging evidence indicates that Piezo1 orchestrates key physiological processes, including electrolyte handling, osmotic regulation, and structural plasticity of the filtration barrier. At the same time, dysregulated Piezo1 signaling links mechanical overload to pathological outcomes such as podocyte injury, tubular dysfunction, fibrosis, and mechano-inflammation, with additional roles suggested in renal tumor progression. Across these contexts, Piezo1 does not function as a simple on-off switch but rather as a context-dependent integrator in which the magnitude, duration, and cellular setting of calcium signaling determine adaptive versus maladaptive responses. This review synthesizes current understanding of Piezo1 as a system-wide renal mechanostat integrating fluid, stretch, and matrix-derived cues across nephron compartments. We discuss how mechanical signaling thresholds shape disease trajectories and explore the emerging concept that therapeutic strategies should aim to retune, rather than silence, mechanotransduction pathways. By placing physical forces at the center of kidney pathophysiology, Piezo1 emerges as both a mechanistic framework for kidney disease and a potential target for future precision interventions.